ARWR
Arrowhead Pharmaceuticals Inc
65.90$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -21.2% | -38.7% | -32.8% | -62.6% | -75.7% | – | – | +200.9% | +0.8% | +102.9% | +7.9% | +188.4% | -83.5% | -52.2% | -50.4% | +97.6% | -39.7% | +118.3% | -58.6% | +19,736.5% | -48.6% | +945.7% | -47.9% | +57.2% | +75.9% | -1.0% | -98.5% | +23,258.2% | |
| – | -82.0% | -57.3% | -26.6% | +200.7% | -98.6% | – | – | +761.7% | +1,042.6% | +60.0% | +26.1% | -39.2% | -45.2% | -94.6% | +552.7% | +81.4% | +20.0% | +2,052.8% | +0.6% | -22.7% | +5.8% | – | – | – | – | +19.9% | +48.8% | +28.7% | |
| – | +35.6% | -36.4% | -33.3% | -86.8% | -27.7% | – | – | -143.9% | – | – | – | – | – | – | -5,788.9% | – | – | – | -58.6% | +19,736.5% | -48.6% | +945.7% | -47.9% | +57.2% | +75.9% | -6.2% | -106.6% | – | |
| – | – | – | – | – | – | – | +23,406.8% | +378.1% | +126.2% | +27.4% | -24.0% | -25.3% | -86.2% | +282.3% | +64.5% | +61.5% | +165.8% | +104.3% | -12.3% | +11.6% | +4.4% | +58.7% | +61.2% | +67.0% | +44.1% | +15.1% | +42.9% | +24.1% | |
| – | +254.1% | +40.6% | +135.0% | -17.2% | +31.6% | -36.7% | +904.6% | +192.6% | +187,964.5% | -12.8% | +56.0% | -99.8% | -43.0% | -17.7% | +114.2% | -17.0% | +108.8% | +42.2% | -32.0% | -25.8% | +9.2% | +39.0% | +96.9% | +54.9% | +53.7% | -26.9% | +6.5% | +25.9% | |
| – | -60.7% | +15.8% | +46.1% | -17.2% | +1,197.9% | -93.3% | +2,960.7% | +222.1% | +47.4% | +29.6% | +2.2% | -33.0% | -63.3% | +120.6% | +97.7% | +4.7% | +132.7% | +72.7% | +0.6% | -22.7% | +5.8% | +53.1% | +69.8% | +64.0% | +46.8% | +2.7% | +35.3% | +24.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -252.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +31,727.6% | +80.2% | -58.4% | -99.7% | +659,171.8% | +13.0% | -63.5% | +56.2% | +152.6% | +563.6% | +32.1% | -99.9% | -17.8% | +264.1% | +76.5% | +176.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -224.1% | – | – | – | – | – | |
| – | -98.7% | -7,062.9% | – | +180.9% | -1,570.7% | – | +0.0% | -342,341.3% | – | – | – | – | -6,119.3% | – | – | – | -99.9% | -54.7% | +0.0% | +0.0% | +0.0% | +7,150.0% | -98.9% | +0.0% | +189,150.0% | -26.4% | -199.4% | – | |
| – | – | – | -123.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -224.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -232.9% | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.